Thomas G McWilliams1, Laura Howard1, Sean Wyatt1, Alun M Davies2. 1. Division of Molecular Biosciences, School of Biosciences, Cardiff University, Museum Avenue, Cardiff CF10 3AX, Wales. 2. Division of Molecular Biosciences, School of Biosciences, Cardiff University, Museum Avenue, Cardiff CF10 3AX, Wales. Electronic address: daviesalun@cf.ac.uk.
Abstract
The regulation of innervation by target-derived factors like nerve growth factor (NGF) is the cornerstone of neurotrophic theory. Whereas autocrine signaling in neurons affecting survival and axon growth has been described, it is difficult to reconcile autocrine signaling with the idea that targets control their innervation. Here, we report that an autocrine signaling loop in developing mouse sympathetic neurons involving CD40L (TNFSF5) and CD40 (TNFRSF5) selectively enhances NGF-promoted axon growth and branching, but not survival, via CD40L reverse signaling. Because NGF negatively regulates CD40L and CD40 expression, this signaling loop operates only in neurons exposed to low levels of NGF. Consequently, the sympathetic innervation density of tissues expressing low NGF is significantly reduced in CD40-deficient mice, whereas the innervation density of tissues expressing high levels of NGF is unaffected. Our findings reveal how differential regulation of autocrine signaling in neurons has region-specific effects on axon growth and tissue innervation.
The regulation of innervation by target-derived factors like nerve growth factor (NGF) is the cornerstone of neurotrophic theory. Whereas autocrine signaling in neurons affecting survival and axon growth has been described, it is difficult to reconcile autocrine signaling with the idea that targets control their innervation. Here, we report that an autocrine signaling loop in developing mouse sympathetic neurons involving CD40L (TNFSF5) and CD40 (TNFRSF5) selectively enhances NGF-promoted axon growth and branching, but not survival, via CD40L reverse signaling. Because NGF negatively regulates CD40L and CD40 expression, this signaling loop operates only in neurons exposed to low levels of NGF. Consequently, the sympathetic innervation density of tissues expressing low NGF is significantly reduced in CD40-deficient mice, whereas the innervation density of tissues expressing high levels of NGF is unaffected. Our findings reveal how differential regulation of autocrine signaling in neurons has region-specific effects on axon growth and tissue innervation.
Neurotrophic theory provides an explanation for how the target
tissues of neuronal populations in the developing peripheral nervous system control
their innervation. The basic idea is that tissues synthesize just the right amount of
a neurotrophic factor to support the survival of the required number of innervating
neurons and promote the growth and branching of their axons within the tissue.
Neurotrophic theory is endorsed by a large body of work on nerve growth factor (NGF),
the first neurotrophic factor to be identified, and has been corroborated by studies
of other members of the NGF family of neurotrophins and by other neurotrophic factors
(Levi-Montalcini, 1987, Davies, 2003, Dekkers et al., 2013). In addition to target-derived
signals, autocrine signaling in neurons involving neurotrophins and other secreted
signaling molecules has been shown to affect neuronal survival, axon growth, and
other aspects of neuronal development and function (Wright et al., 1992, Acheson et al., 1995, O’Keeffe et al., 2008, Cheng et al., 2011, Ryu et al., 2013). However, neuronal autocrine signaling is difficult to
reconcile with neurotrophic theory because it is not clear how autonomous signaling
loops in neurons could contribute to the establishment of distinctive patterns of
tissue innervation.From a PCR screen to identify novel regulators of neuronal survival
and axon growth, we detected expression of transcripts encoding CD40L (TNFSF5), a
member of the tumor necrosis factor superfamily (TNFSF), and CD40 (TNFRSF5), a member
of the TNF receptor superfamily (TNFRSF), in the experimentally tractable sympathetic
neurons of the mouse superior cervical ganglion (SCG) at the stage when the axons of
these neurons are ramifying extensively in their target tissues. CD40L and CD40 are
prominently expressed in the immune system, where they play a central role in the
generation of immune responses and the pathogenesis of autoimmune disease
(Calderhead et al., 2000, Peters et al., 2009). Whereas there is some evidence for the
appearance of a neurodegenerative phenotype in aged CD40 knockout mice (Tan et al., 2002), CD40 and CD40L
are not known to play any role in neural development. We demonstrate that CD40
autocrine signaling enhances NGF-promoted axonal growth and branching, is regulated
by the level of NGF in targets, and exerts regional effects on innervation density
in vivo. These findings resolve the long-standing conundrum of neuronal autocrine
signaling by uncovering a mechanism of differential regulation of autocrine signaling
within neuronal populations, resulting in specific regional effects on tissue
innervation.
Results
CD40 and CD40L Are Co-expressed in Perinatal
SCG Neurons
Quantitative PCR revealed the expression of
Cd40 and Cd40l transcripts in the
SCG of late fetal and early postnatal mice during the stage when sympathetic axons
are ramifying extensively in their targets (Figure 1A).
Compared with adult spleen, where CD40 and CD40L are expressed at very high
levels, the levels of Cd40 mRNA and
Cd40l mRNA were 8.8-fold and 950-fold lower,
respectively, in the SCG at P5. Western blotting confirmed the presence of CD40
and CD40L protein in the developing SCG (Figure 1B). In dissociated SCG cultures, the
great majority of neurons, positively identified by βIII-tubulin labeling, were
labeled by anti-CD40 (91.5 ± 2.4; mean ± SEM) and by anti-CD40L (87.4 ± 2.0;
Figure 1C). The
small number of non-neuronal cells in these cultures exhibited a very low level of
CD40 and CD40L immunostaining. No neurons were labeled when primary antibodies
were omitted, and anti-CD40 did not label neurons cultured from
Cd40−/− mice. These observations
suggest that the great majority of sympathetic neurons co-express CD40 and CD40L
when sympathetic axons are innervating their targets.
Figure 1
SCG Neurons Express CD40 and CD40L
(A) Levels of Cd40 and
Cd40l mRNA relative to reference mRNAs in SCG of different
ages. The data are normalized to a value of 1.0 at the peak of expression at P5. Mean
± SEM of data from three separate sets of ganglia at each age is
shown.
(B) Representative western blot of lysates of SCG of
different ages.
(C) Images of representative P3 SCG neurons cultured for
24 hr in medium containing 1 ng/ml NGF labeled with either anti-CD40 or anti-CD40L.
The scale bar represents 50 μm.
The co-expression of CD40L and CD40 raised the possibility of
autocrine signaling. To test this possibility and to ascertain how autocrine
signaling might influence SCG neuron development, we studied the effects of
blocking the interaction of CD40L and CD40 using function-blocking antibodies and
quantified neuronal survival and neurite growth. Whereas NGF-promoted neuronal
survival was unaffected by these antibodies (Figure S1A), neurite arbor size and complexity
were markedly reduced. In the presence of NGF, each function-blocking antibody
caused highly significant reductions in total length (Figure 2A) and
branch point number (Figure 2B) compared with isotype control antibodies.
Representative images of neurons grown under these conditions are shown in
Figure S1B. Because
these data were obtained from non-contiguous neurons cultured at exceptionally low
density, these findings suggest that CD40 autocrine signaling enhances
NGF-promoted neurite growth but does not affect NGF-promoted survival.
(A and B) Neurite arbor length (A) and branch point
number (B) of P3 SCG neurons cultured for 24 hr with 1 ng/ml NGF plus
function-blocking anti-CD40, function-blocking anti-CD40L, or isotype control
antibodies (2 μg/ml).
(C) Neurite arbor length of P3 SCG neurons cultured for
24 hr in media supplemented with 1 ng/ml NGF alone (control) or 1 ng/ml NGF plus
isotype control antibodies (Iso control), Fc fragment (Fc control), function-blocking
anti-CD40 and anti-CD40L (FB antibodies), 1 μg/ml CD40L, or 1 μg/ml
CD40-Fc.
(D) Neurite arbor length of SCG neurons obtained from P3
Cd40−/− littermates cultured under the
same conditions as in (C). ∗∗∗∗p < 0.0001;
∗∗∗p < 0.001, ANOVA with Bonferroni
correction, statistical comparison with controls.
(E) Sholl plots of neurite arbors of E17–P10 SCG neurons
cultured for 24 hr with 1 ng/ml NGF plus either function blocking or isotype control
antibodies.
(F) Sholl plots of the neurite arbors of P3 SCG neurons
of Cd40+/+ and
Cd40−/− littermates grown for 24 hr with a
concentration range of NGF and 25 μM Boc-D-FMK to prevent apoptosis at low NGF
concentrations. Mean ± SEM data of >150 neurons per condition combined from three to
five experiments of each type.
Interaction of CD40 and membrane-integrated CD40L can initiate
bi-directional signaling: CD40-mediated forward signaling and CD40L-mediated
reverse signaling (Sun and Fink,
2007). To determine whether CD40/CD40L interaction enhances
NGF-promoted axon growth by either forward or reverse signaling, we ascertained
whether either soluble CD40L or soluble CD40-Fc chimera (in which the
extracellular domain of CD40 is linked to the Fc part of humanIgG1) interferes
with NGF-promoted axon growth. Whereas soluble CD40L reduced NGF-promoted axon
growth to the same extent as the function-blocking anti-CD40 and anti-CD40L
antibodies, CD40-Fc had no significant effect on NGF-promoted axon growth
(Figure 2C). The
most parsimonious explanation for these results is that the added soluble CD40L
competes with endogenous membrane-integrated CD40L for binding to endogenous CD40
and thereby blocks endogenous CD40L-mediated reverse signaling. Further support
for reverse signaling came from the phenotype rescue experiments on SCG neurons
obtained from Cd40−/− mice. The extent of NGF-promoted axon
growth from these neurons was similar to that of SCG neurons of wild-type
littermates treated with function-blocking anti-CD40 and anti-CD40L antibodies
(Figure 2D). CD40-Fc
fully restored the extent of NGF-promoted axon growth from CD40-deficient neurons
to that of wild-type neurons, suggesting that soluble, rather than
membrane-integrated CD40, is sufficient to rescue the impaired axon growth
phenotype of these neurons. The observation that neither soluble CD40L nor
function-blocking antibodies reduced the extent of NGF-promoted axon growth from
CD40-deficient neurons (Figure 2D) additionally shows that these reagents do not exert
non-specific suppressive effects on axon growth.
CD40 Signaling Enhances NGF-Promoted Axon Growth
during a Perinatal Window
To ascertain whether CD40 autocrine signaling reduces
NGF-promoted neurite growth during a particular period of sympathetic neuron
development, we examined the effect of function-blocking anti-CD40L and anti-CD40
in cultures established over a range of ages. Sholl analysis showed that these
antibodies decreased NGF-promoted neurite growth most markedly in P0 and P3 SCG
cultures (Figure 2E).
Quantification of neurite length and branching revealed consistent decreases at
E17 and P5, but these decreases did not reach significance (p > 0.05; t tests; n =
3 experiments at each age). Highly significant decreases in neurite length and
branching were observed in P0 and P3 cultures (p < 0.0001 for length and
branching at P0; p < 0.05 for length and p < 0.0001 for branching at P3;
unpaired two-tailed t test; n = 3 experiments at each age). No consistent effect
of the antibodies on neurite length and branching were observed in P10 cultures.
These findings suggest that CD40L autocrine signaling enhances NGF-promoted
neurite growth from SCG neurons maximally during the period of development when
SCG axons are ramifying extensively in their target tissues under the influence of
target-derived NGF (Davies,
2009).
CD40 Signaling Enhances Axon Growth Promoted
by Low Concentrations of NGF
To provide a more stringent test of the effect of CD40 signaling
on NGF-promoted neurite growth, we compared the size and complexity of the neurite
arbors of SCG neurons obtained from neonatal CD40-deficient mice and wild-type
littermates. Detailed dose-response analysis revealed that absence of CD40 reduced
NGF-promoted neurite growth over a restricted range of low NGF concentrations. In
cultures containing 0.01, 0.1, and 1 ng/ml NGF, the neurite arbors of
CD40-deficient neurons were markedly smaller and less complex than those of
wild-type mice, whereas at lower and higher concentrations of NGF, there were no
significant differences in neurite arbor size and complexity (Figure 2F). All cultures received
the broad-spectrum caspase inhibitor Boc-D-FMK to prevent apoptosis at low levels
of NGF. The great majority of neurons survived in these experiments, and there
were no significant differences in survival between the experimental groups (not
shown). These findings suggest that CD40 signaling does not affect neurite growth
on its own but enhances NGF-promoted neurite growth and branching over a narrow
range of low NGF concentrations.
NGF Negatively Regulates Expression of CD40L
and CD40
The lack of effect of Cd40 deletion on
neurite growth at high NGF concentrations could be due to negative regulation of
the expression of CD40L and/or CD40 by NGF. To test this possibility, SCG neurons
were cultured with a range of NGF concentrations and western blotting was used to
assess the relative levels of CD40L and CD40 after 48 hr. This analysis revealed a
clear decrease in the levels of both proteins with increasing levels of NGF
(Figures
3A–3C). Because the levels of
Cd40 mRNA are much higher than those of
Cd40l mRNA and can be easily and accurately quantified
by qPCR in low-density SCG cultures, we carried further detailed analysis of the
influence of NGF on Cd40 mRNA expression. There was a very
clear inverse relationship between the levels of NGF and
Cd40 mRNA, with a very marked decrease in
Cd40 mRNA at NGF concentrations between 0.01 and 1 ng/ml
(Figure 3D). To
ascertain whether these marked differences in Cd40 mRNA
observed at 48 hr were due to increases and/or decreases in
Cd40 mRNA with time in culture, we measured the levels
of Cd40 mRNA in freshly dissociated SCG neurons and in SCG
neurons cultured for 24 and 48 hr with and without 10 ng/ml NGF. In cultures
containing NGF, there was an ∼60% decrease in the level of
Cd40 mRNA relative to the level in freshly dissociated
SCG neurons after 24 hr in culture and a further decrease by 48 hr (Figure 3E). In contrast, there was
a marked ∼8-fold increase in the level of Cd40 mRNA during
the first 24 hr in cultures lacking NGF and a further increase by 48 hr
(Figure 3F). These
data indicate that Cd40 mRNA expression increases in the
absence of NGF and is decreased by relatively high levels of NGF.
Figure 3
Negative Regulation of CD40 Expression by
NGF
(A) Representative western blots of P3 SCG neuron
lysates probed for CD40 and CD40L after 48 hr culture with different levels of NGF.
All cultures received 25 μM Boc-D-FMK.
(B) Densitometry for CD40 from multiple western
blots.
(C) Densitometry for CD40L from multiple western
blots.
(D–F) Level of Cd40 mRNA in P3
SCG cultures grown with a range of NGF concentrations for 48 hr (D) or for 24 and
48 hr with 10 ng/ml NGF (E) or without NGF (F). Data normalized to 1.0 at plating
(n = 3 experiments).
Mean ± SEM data combined from three to five experiments
of each type.
Sympathetic Innervation of Tissue Expressing Low,
but Not High, Levels of NGF Is Reduced in Mice Lacking CD40
To assess the physiological relevance of our in vitro findings,
we studied the sympathetic innervation of several tissues that express markedly
different levels of NGF. Western analysis showed that the densely innervated
submandibular salivary gland and nasal turbinate tissue express much higher levels
of mature NGF than the sparsely innervated thymus and periorbital cutaneous tissue
(Figure 4A). These differences in
NGF level accord with earlier studies that reported relatively high levels of NGF
and Ngf mRNA in the submandibular salivary gland compared
with the thymus (Shelton and Reichardt, 1984, Heumann et al., 1984).
Figure 4
Reduced Sympathetic Innervation of Low-NGF-Expressing,
but Not High-NGF-Expressing, Tissue in CD40-Deficient Mice
(A) Representative western blot of P3 submandibular
salivary gland (SMG), P3 nasal tissue, P3 thymus, and E16.5 periorbital cutaneous
tissue probed for NGF, showing the band corresponding to mature NGF.
(B and C) Scatterplots of sympathetic innervation
density in P3 SMG (B) and P3 nasal turbinate tissue (C).
(D and E) Representative images of P3 thymus whole
mounts of Cd40+/+ and
Cd40−/− mice stained for TH-positive
sympathetic fibers (D) and scatterplots of innervation density (E).
(F and G) Representative images of whole mounts of E16.5
periorbital cutaneous tissue of Cd40+/+ and
Cd40−/− mice stained for TH-positive
sympathetic fibers (F) and scatterplots of innervation density (G). Mean ± SEM.
∗∗p < 0.01; t test.
The scale bars represent 100 μm.
We assessed sympathetic innervation density by quantifying
immunostaining for tyrosine hydroxylase, a rate-limiting enzyme for noradrenaline
synthesis specifically expressed in sympathetic fibers. Innervation density in the
densely innervated submandibular salivary gland and nasal turbinate tissue was
assessed by quantifying tyrosine hydroxylase staining in histological sections
(Kisiswa et al.,
2013). Because there are so few sympathetic fibers in the thymus
and periorbital cutaneous tissue, we assessed innervation density by quantifying
tyrosine-hydroxylase-positive fibers in cleared whole-mount tissue preparations
(Kisiswa et al.,
2013). Quantification of sympathetic innervation density in the
submandibular salivary gland, nasal turbinate tissue, and thymus was carried out
at P3 when sympathetic innervation is well established. However, in order to
visualize cutaneous sympathetic fibers in cleared whole-mount preparations
adequately, it was necessary to examine this tissue in late fetal mice at E16.5
(Glebova and Ginty,
2004). Quantification of sympathetic innervation density in the
high-NGF-expressing submandibular salivary gland and nasal turbinate tissue
revealed no significant differences between
Cd40+/+ and
Cd40−/− mice (Figures 4B and 4C). Representative
tyrosine-hydroxylase-stained sections of these tissues are shown in Figures S2A and S2B. In contrast,
there were highly significant reductions in the sympathetic innervation density of
the thymus and periorbital cutaneous tissue of
Cd40−/− mice compared with
Cd40+/+ mice (Figures 4D–4G). These findings
suggest that CD40 signaling selectively enhances the sympathetic innervation of
low-NGF-expressing, but not high-NGF-expressing, tissue.
Discussion
We have uncovered an autocrine-signaling loop in developing
sympathetic neurons involving CD40 and CD40L that enhances NGF-promoted neurite
growth but has no effect on NGF-promoted survival. This autocrine-signaling loop has
no effect on neurite growth on its own and only enhances neurite growth from neurons
cultured with NGF over a low concentration range. The reduction of NGF-promoted axon
growth by soluble CD40L, but not by CD40-Fc, together with the rescue of the reduced
axon growth phenotype of CD40-deficient neurons by CD40-Fc suggests that enhancement
of NGF-promoted axon growth by the CD40/CD40L autocrine-signaling loop occurs by
CD40L-mediated reverse signaling. In addition to CD40L, several other members of the
TNFSF, including TNF, FasL, LIGHT, GITRL, and APRIL, have been shown to either
enhance or repress axon growth from a variety of developing neurons (Desbarats et al., 2003, Gutierrez et al., 2008, Gutierrez et al., 2013, Gavaldà et al., 2009, McKelvey et al., 2012, Kisiswa et al., 2013, Osório et al., 2014, Wheeler et al., 2014). Of these, only TNF has been shown to affect axon growth by
reverse signaling (Kisiswa et al., 2013, Wheeler et al., 2014). Our findings not only extend
the importance of the TNFSF in regulating axon growth in neural development but show
that reverse signaling is not restricted to TNF in the nervous system.The negative regulation of CD40 and CD40L expression by NGF explains
why the effects of CD40/CD40L autocrine signaling on axon growth are curtailed at
higher NGF concentrations. The physiological relevance of our in vitro observations
was confirmed by quantification of sympathetic innervation density of tissues that
express different levels of NGF. In CD40-deficient mice, the sympathetic innervation
density of the low-NGF-expressing thymus and periorbital cutaneous tissue was
significantly reduced compared with wild-type littermates, whereas the sympathetic
innervation density of the high-NGF-expressing submandibular salivary gland and nasal
turbinate tissue was unaffected. The growth and branching of sympathetic fibers in at
least two of these tissues, the periorbital cutaneous tissue and the submandibular
salivary gland, has been shown to be critically dependent on NGF in vivo
(Glebova and Ginty,
2004). Our findings therefore suggest that CD40 signaling
selectively modulates NGF-dependent innervation in vivo and reveal a fundamentally
novel mechanism for adjusting the innervation density of specific tissues based on
the differential regulation of an autocrine-signaling loop in the innervating
population of neurons in accordance with the level of NGF in the tissue they
innervate. Because some members of the TNFSF, such as GITRL and APRIL, appear to act
by an autocrine mechanism, our current findings raise the possibility that analogous
paradigms might operate in regulating tissue innervation by these
cytokines.Why has such a mechanism evolved? Because NGF promotes both survival
and axon growth in the developing peripheral nervous system, it might not be possible
to attain the physiologically appropriate innervation density of particular tissues
by a limited number of neurons if there was an invariant relationship between the
survival-promoting and axon-growth-promoting effects of NGF. For example, whereas a
low level of NGF in certain tissues may be sufficient to support the required number
of innervating neurons, this may be inadequate to promote enough axon growth and
branching for optimal sympathetic function. The CD40 autocrine-signaling loop breaks
an otherwise invariant relationship between survival and axon growth, facilitating
physiologically appropriate innervation density by a limited number of neurons in
low-NGF-expressing tissue. In future work, it will be informative to ascertain how
CD40L-mediated reverse signaling influences downstream NGF signaling to modulate axon
growth selectively and how extensively this and analogous paradigms of autocrine
signaling operate in the nervous system.
Experimental Procedures
Primary Neuron Culture
SCGs were dissected from mice that were bred and housed in
accordance with guidelines approved by the Cardiff University Ethical Review Board
and the Home Office Animals (Scientific Procedures) Act, 1986. SCG neurons were
cultured at very low density on poly-ornithine- and laminin-coated 4-well tissue
culture dishes in defined medium. Neurite arbors were labeled by the fluorescent
vital dye calcein-AM after 24 hr, and the images were analyzed to obtain neurite
length, branch point number, and Sholl profiles (Gutierrez and Davies, 2007).
Quantitative PCR
The levels of Cd40l and
Cd40 mRNAs were quantified by real-time PCR relative to
a geometric mean of mRNAs for house-keeping enzymes. See Supplemental Information for
primer details and reaction conditions.
Immunohistochemistry and
Immunocytochemistry
Tissue and cultures were fixed in 4% paraformaldehyde in 0.12 M
phosphate buffer. Frozen sections were cut at 14 μm, and permeabilized cultures
were incubated for 18 hr at 4°C with primary antibody (anti-tyrosine hydroxylase,
anti-CD40, or anti-CD40L). After washing, the tissue and cultures were incubated
for 1 hr with donkey anti-rabbitAlexa 488 antibody, washed, and imaged by
confocal microscopy.
Immunoblotting
Tissue and neuron cultures were lysed in RIPA lysis buffer
containing protease and phosphatase inhibitors. After removal of insoluble
material by centrifugation, protein concentration was determined by Bradford assay
and equal quantities of protein were separated on 10% SDS-PAGE gels and were
transferred to PVDF membranes. After blocking, the membranes were incubated with
primary antibodies overnight at 4°C. After washing, the membranes were incubated
with HRP-conjugated secondary antibodies and the blots were developed by
chemiluminescence.
Whole-Mount Preparations
Paraformaldehyde fixed tissue was processed to label
tyrosine-hydroxylase-positive sympathetic fibers by DAB-HRP staining followed by
clearing in benzyl alcohol:benzyl benzoate as described previously (Kisiswa et al., 2013) with
modifications (Supplemental
Information).
Quantification of Sympathetic Innervation
Density
Tissue from
Cd40 and
Cd40
littermates was processed at the same time, and quantification was done blind.
Sympathetic fiber density in the submandibular gland and nasal turbinate tissue
was carried out on TH-labeled images of every fifth section through the tissue
using NIH-ImageJ to estimate TH-positive fibers per unit area. Sympathetic fiber
density in the thymus and periorbital cutaneous tissue was analyzed in TH-labeled
whole-mount preparations. TH-positive fibers per unit image area were estimated
from manually traced fibers in Adobe Photoshop images of the tissue.
Author Contributions
T.G.M. and L.H. did the cell culture, T.G.M. quantified tissue
innervation, L.H. undertook the western analysis, S.W. carried out the qPCR, A.M.D.
and S.W. supervised the project, and A.M.D. wrote the manuscript.
Authors: A Acheson; J C Conover; J P Fandl; T M DeChiara; M Russell; A Thadani; S P Squinto; G D Yancopoulos; R M Lindsay Journal: Nature Date: 1995-03-30 Impact factor: 49.962
Authors: Lilian Kisiswa; Catarina Osório; Clara Erice; Thomas Vizard; Sean Wyatt; Alun M Davies Journal: Nat Neurosci Date: 2013-06-09 Impact factor: 24.884
Authors: Humberto Gutierrez; Lilian Kisiswa; Gerard W O'Keeffe; Matthew J Smithen; Sean Wyatt; Alun M Davies Journal: Open Biol Date: 2013-01-08 Impact factor: 6.411
Authors: K D Kuhn; K Edamura; N Bhatia; I Cheng; S A Clark; C V Haynes; D L Heffner; F Kabir; J Velasquez; A J Spano; C D Deppmann; A B Keeler Journal: Mol Cell Neurosci Date: 2020-01-28 Impact factor: 4.314
Authors: Gerard W O'Keeffe; Humberto Gutierrez; Laura Howard; Christopher W Laurie; Catarina Osorio; Núria Gavaldà; Sean L Wyatt; Alun M Davies Journal: Neural Dev Date: 2016-02-15 Impact factor: 3.842
Authors: Shane V Hegarty; Sean L Wyatt; Laura Howard; Elke Stappers; Danny Huylebroeck; Aideen M Sullivan; Gerard W O'Keeffe Journal: Sci Rep Date: 2017-08-17 Impact factor: 4.379
Authors: Lilian Kisiswa; Clara Erice; Laurent Ferron; Sean Wyatt; Catarina Osório; Annette C Dolphin; Alun M Davies Journal: Open Biol Date: 2017-01 Impact factor: 6.411
Authors: Laura Howard; Erin Wosnitzka; Darian Okakpu; Matthew A White; Sean Wyatt; Alun M Davies Journal: Development Date: 2018-11-19 Impact factor: 6.862